THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry Parameters

Retina. 2019 Feb;39(2):319-330. doi: 10.1097/IAE.0000000000001982.

Abstract

Purpose: To evaluate the effects of ocriplasmin and symptomatic vitreomacular adhesion resolution on visual fixation and macular sensitivity using microperimetry.

Methods: MP-1 parameters were analyzed from 3 OASIS sites after the use of standardized instruments and testing procedures over 24 months.

Results: A total of 27 patients (19 ocriplasmin, 8 sham) were evaluated. Mean distance of the preferred fixation locus to the anatomical center was farther in the sham group at baseline and farther in the sham versus ocriplasmin group throughout the study. Retinal sensitivity values were consistently higher in the ocriplasmin versus sham group after Month 3. Fewer patients in the ocriplasmin group had predominantly eccentric fixation at study end compared with the sham group, which also had an increased number of patients with unstable fixation. Patients with vitreomacular adhesion resolution had lower bivariate contour area, fewer relative scotomas, and higher retinal sensitivity parameters at baseline than those with unresolved vitreomacular adhesion.

Conclusion: Substudy results suggest that fixation and sensitivity parameters tended to be better in the ocriplasmin group than in the sham group over time. The substudy identified parameters that were distinct between patients with and without vitreomacular adhesion resolution, suggesting that microperimetry warrants further study as a relevant biomarker for visual function.

Publication types

  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cross-Over Studies
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Female
  • Fibrinolysin / administration & dosage*
  • Follow-Up Studies
  • Humans
  • Intravitreal Injections
  • Macula Lutea / pathology
  • Male
  • Middle Aged
  • Peptide Fragments / administration & dosage*
  • Retinal Perforations / diagnosis
  • Retinal Perforations / drug therapy*
  • Retinal Perforations / etiology
  • Time Factors
  • Tissue Adhesions / drug therapy
  • Tissue Adhesions / pathology
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Visual Acuity*
  • Visual Field Tests / methods*
  • Visual Fields / physiology*
  • Vitreous Body / pathology
  • Vitreous Detachment / complications
  • Vitreous Detachment / diagnosis
  • Vitreous Detachment / drug therapy*

Substances

  • Peptide Fragments
  • microplasmin
  • Fibrinolysin